Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Onody, C.
Right arrow Articles by Nauciel, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Onody, C.
Right arrow Articles by Nauciel, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 39, 815-816, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy

JOURNAL ARTICLE

Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila

C Onody, P Matsiota-Bernard and C Nauciel
Laboratoire de Microbiologie, Hopital Raymond Poincare, Garches, France.

Ninety-eight consecutive clinical isolates of Legionella pneumophila were tested for erythromycin, rifampicin and ciprofloxacin susceptibility. MICs, determined by agar dilution testing, were in the range 0.06-1 mg/L of erythromycin, 0.007-0.015 mg/L of rifampicin and 0.015-0.03 mg/L of ciprofloxacin. No resistance against the antibiotics tested was detected. It is thus likely that therapeutic failures in legionnaires' disease are not related to the emergence of resistance against commonly used antimicrobial agents.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
N. Roch and M. Maurin
Antibiotic susceptibilities of Legionella pneumophila strain Paris in THP-1 cells as determined by real-time PCR assay
J. Antimicrob. Chemother., June 1, 2005; 55(6): 866 - 871.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. Roig and J. Rello
Legionnaires' disease: a rational approach to therapy
J. Antimicrob. Chemother., May 1, 2003; 51(5): 1119 - 1129.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Dedicoat and P. Venkatesan
The treatment of Legionnaires' disease
J. Antimicrob. Chemother., June 1, 1999; 43(6): 747 - 752.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
O. S. Harb and Y. A. Kwaik
Identification of the Aspartate-beta -Semialdehyde Dehydrogenase Gene of Legionella pneumophila and Characterization of a Null Mutant
Infect. Immun., May 1, 1998; 66(5): 1898 - 1903.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.